Validation of the EVendo score for the prediction of varices in cirrhotic patients

Background: Screening endoscopy for varices may be deferred when the calculated EVendo score is ≤3.90. This novel score has not been validated in an external cohort. This study aimed to assess the performance of the EVendo score and compare it with the Baveno VI criteria. Methods: We identified and calculated this score in all cirrhotic patients who underwent screening endoscopy for the first time with laboratory tests and liver stiffness measurements within 6 months of the endoscopy date. Results: In total, 103 patients were included. An EVendo score of ≤3.90 identified patients with no gastroesophageal varices (GEV) and varices needing treatment (VNT) with sensitivities of 82% and 83% and specificities of 57% and 34%, respectively. The negative predictive value for VNT was 94%. A comparison with the Baveno VI criteria in Child–Turcotte–Pugh-A patients showed spared endoscopy and missed VNT rates with EVendo score cutoffs of ≤3.9 and ≤4.5 and the Baveno VI criteria of 25%, 33%, and 16.6% and 1.7%, 1.7%, and 0%, respectively. Conclusions: EVendo score is reliable in clinical practice for predicting GEV and VNT. The number of spared endoscopies was higher than that with the Baveno VI criteria; however, there were more missed VNT cases.

[1]  猪口 貞樹.  Correction: UK guidelines on the management of variceal haemorrhage in cirrhotic patients , 2022, Gut.

[2]  S. Bangaru,et al.  Noninvasive scores for the prediction of esophageal varices and risk stratification in patients with cirrhosis , 2020, World journal of hepatology.

[3]  Hong Zhou,et al.  Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria , 2019, World journal of gastroenterology.

[4]  F. Schacher,et al.  Screening for esophageal varices in cirrhotic patients - Non-invasive methods. , 2019, Annals of hepatology.

[5]  Keith D. Lindor,et al.  Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  A. Tsapas,et al.  Performance of Baveno VI and Expanded Baveno VI Criteria for Excluding High-Risk Varices in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[7]  Yi-da Yang,et al.  External validation of Liaoning score for predicting esophageal varices in liver cirrhosis: a Chinese multicenter cross-sectional study. , 2019, Annals of translational medicine.

[8]  M. Abecassis,et al.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2019, Clinical Liver Disease.

[9]  D. Sinn,et al.  Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[10]  V. Wong,et al.  Repeating measurements by transient elastography in non‐alcoholic fatty liver disease patients with high liver stiffness , 2018, Journal of gastroenterology and hepatology.

[11]  R. Kiesslich,et al.  Acute sedation-associated complications in GI endoscopy (ProSed 2 Study): results from the prospective multicentre electronic registry of sedation-associated complications , 2018, Gut.

[12]  J. Bosch,et al.  Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease , 2017, Hepatology.

[13]  Marta Hernández,et al.  Validation of noninvasive methods to predict the presence of gastroesophageal varices in a cohort of patients with compensated advanced chronic liver disease , 2017, Journal of gastroenterology and hepatology.

[14]  G. Garcia‐Tsao,et al.  Validating, deconstructing and refining Baveno criteria for ruling out high‐risk varices in patients with compensated cirrhosis , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[15]  J. Bosch,et al.  Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases , 2017, Hepatology.

[16]  M. Pinzani,et al.  Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices. , 2016, Journal of hepatology.

[17]  John A. Evans,et al.  The role of endoscopy in the management of variceal hemorrhage. , 2014, Gastrointestinal endoscopy.

[18]  K. Shi,et al.  Performance of Platelet Count/Spleen Diameter Ratio for Diagnosis of Esophageal Varices in Cirrhosis: A Meta-Analysis , 2012, Digestive Diseases and Sciences.

[19]  D. Thabut,et al.  Oesophageal varices in cirrhotic patients: from variceal screening to primary prophylaxis of the first oesophageal variceal bleeding , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[20]  V. Wong,et al.  Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B , 2009, Journal of gastroenterology and hepatology.

[21]  Gunda Millonig,et al.  Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis , 2008, Hepatology.

[22]  A. Sanyal,et al.  Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis , 2007, The American Journal of Gastroenterology.

[23]  R. Testa,et al.  Platelet Count/Spleen Diameter Ratio for the Noninvasive Diagnosis of Esophageal Varices: Results of a Multicenter, Prospective, Validation Study , 2006, The American Journal of Gastroenterology.

[24]  B. Spiegel,et al.  Endoscopic screening for esophageal varices in cirrhosis: Is it ever cost effective? , 2003, Hepatology.

[25]  J. Lapidus,et al.  Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. , 2001, Archives of internal medicine.

[26]  D. Rockey,et al.  Gastroesophageal variceal hemorrhage. , 2001, The New England journal of medicine.

[27]  P. Hayes,et al.  UK guidelines on the management of variceal haemorrhage in cirrhotic patients , 2000, Gut.

[28]  G. Cioni,et al.  A prospective study of the ability of three endoscopic classifications to predict hemorrhage from esophageal varices. , 1992, Gastrointestinal endoscopy.

[29]  R. de Franchis.  Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. , 2015, Journal of hepatology.

[30]  J. Fermanian,et al.  Gastroesophageal endoscopic features in cirrhosis. Observer variability, interassociations, and relationship to hepatic dysfunction. , 1990, Gastroenterology.